[Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D004983:Ethanolamines; D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D014280:Triglycerides
Essai thérapeutique d'un normolipémiant le N-oxy-nicotinate d'éthanolamine